Abstract
Recent experiments have demonstrated that the Polycomb group (PcG) gene EZH2 is highly expressed in metastatic prostate cancer and in lymphomas. EZH2 is a component of the PRC2 histone methyltransferase complex, which also contains EED and SUZ12 and is required for the silencing of HOX gene expression during embryonic development. Here we demonstrate that both EZH2 and EED are essential for the proliferation of both transformed and non‐transformed human cells. In addition, the pRB‐E2F pathway tightly regulates their expression and, consistent with this, we find that EZH2 is highly expressed in a large set of human tumors. These results raise the question whether EZH2 is a marker of proliferation or if it is actually contributing to tumor formation. Significantly, we propose that EZH2 is a bona fide oncogene, since we find that ectopic expression of EZH2 is capable of providing a proliferative advantage to primary cells and, in addition, its gene locus is specifically amplified in several primary tumors.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Andersen CL et al. (2002) High‐throughput copy number analysis of 17q23 in 3520 tissue specimens by fluorescence in situ hybridization to tissue microarrays. Am J Pathol, 161, 73–79.
Beier R et al. (2000) Induction of cyclin E‐cdk2 kinase activity, E2F‐dependent transcription and cell growth by Myc are genetically separable events. EMBO J, 19, 5813–5823.
Brock HW and van Lohuizen M (2001) The Polycomb group—no longer an exclusive club? Curr Opin Genet Dev, 11, 175–181.
Cao R, Wang L, Wang H, Xia L, Erjument‐Bromage H, Tempst P, Jones RS and Zhang Y (2002) Role of Histone H3 Lysine 27 methylation in Polycomb‐Group silencing. Science, 298, 1039–1043.
Cardoso C, Mignon C, Hetet G, Grandchamps B, Fontes M and Colleaux I (2000) The human EZH2 gene: genomic organisation and revised mapping in 7q35 within a critical region of malignant disorders. Eur J Hum Genet, 8, 174–180.
Czermin B, Melfi R, McCabe D, Seitz V, Imhof A and Pirotta V (2002) Drosophila Enhancer of Zeste/ESC complexes have a histone H3 methyltransferase activity that marks chromosomal polycomb sites. Cell, 111, 185–196.
Dahiya A, Wong S, Gonzalo S, Gavin M and Dean DC (2001). Linking the Rb and polycomb pathways. Mol Cell, 8, 557–569.
Dyson N (1998) The regulation of E2F by pRB‐family proteins. Genes Dev, 12, 2245–2262.
Frank SR, Schroeder M, Fernandez P, Taubert S and Amati B (2001) Binding of c‐Myc to chromatin mediates mitogen‐induced acetylation of histone H4 and gene activation. Genes Dev, 15, 2069–2082.
Fukuyama T, Otsuka T, Shigematsu H, Uchida N, Arima F, Ohno Y, Iwasaki H, Fukuda T and Niho Y (2000) Proliferative involvement of ENX‐1, a putative human Polycomb gene, in haematopoietic cells. Br J Haematol, 108, 842–847.
Gildea JJ, Lopez R and Shearn A (2000) A screen for new trithorax group genes identified little imaginal discs, the Drosophila melanogaster homologue of human retinoblastoma binding protein 2. Genetics, 156, 645–663.
Hanahan D and Weinberg RA (2000) The hallmarks of cancer. Cell, 100, 57–70.
Helin K (1998) Regulation of cell proliferation by the E2F transcription factors. Curr Opin Genet Dev, 8, 28–35.
Jacobs JJL and van Lohuizen M (2002) Polycomb repression: from cellular memory to cellular proliferation and cancer. Biochim Biophys Acta, 1602, 151–161.
Jacobs JJL, Kieboom K, Marino S, DePinho RA and van Lohuizen M (1999) The oncogene and Polycomb‐group gene bmi‐1 regulates cell proliferation and senescence through the ink4a locus. Nature, 397, 164–168.
Jiang H, Chou HS and Zhu L (1998) Requirement of Cyclin E‐Cdk2 in p16INK4a mediated growth suppression. Mol Cell Biol, 18, 5284–5290.
Kononen J et al. (1998) Tissue microarrays for high‐throughput molecular profiling of tumor specimens. Nat Med, 4, 844–847.
Koontz JI, Soreng AL, Nucci M, Kuo FC, Pauwels P, van den Berghe H, Cin PD, Rechter JA and Sklar J (2001) Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors. Proc Natl Acad Sci USA, 98, 6348–6353.
Kuzmichev A, Nishioka K, Erdjument‐Bromage H, Tempst P and Reinberg D (2002) Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein. Genes Dev, 16, 2893–2905.
LaJeunesse D and Shearn A (1996) E(z): a polycomb group gene or a trithorax group gene? Development, 122, 2189–2197.
Lin L et al. (2000) Identification and characterization of a 19q12 amplicon in esophageal adenocarcinomas reveals cyclin E as the best candidate gene for this amplicon. Cancer Res, 60, 7021–7027.
Lipinski MM and Jacks T (1999) The retinoblastoma gene family in differentiation and development. Oncogene, 18, 7873–7882.
Lukas J, Sørensen CS, Lukas C, Santoni‐Rugiu E and Bartek J (1999) p16INK4a, but not constitutively active pRb, can impose a sustained G1 arrest: molecular mechanisms and implications for oncogenesis. Oncogene, 18, 3930–3935.
Müller H et al. (2001) E2Fs regulate the expression of genes involved in differentiation, development, proliferation and apoptosis. Genes Dev, 15, 267–285.
Müller J et al. (2002) Histone methyltransferase activity of a Drosophila Polycomb group repressor complex. Cell, 111, 197–208.
Myster DL, Bonnette PC and Duronio RJ (2000) A role for the DP subunit of the E2F transcription factor in axis determination during Drosophila oogenesis. Development, 127, 3249–3261.
O’Caroll D, Erhardt S, Pagani M, Barton SC, Surani MA and Jenuwein T (2001) The polycomb group gene Ezh2 is required for early mouse development. Mol Cell Biol, 21, 4330–4336.
Pollack JR et al. (2002) Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Natl Acad Sci USA, 99, 12963–12968.
Raaphorst FM, van Kememade FJ, Fieret E, Hamer KM, Satijn DPE, Otte AP and Meijer CJLM (2000) Cutting edge: Polycomb gene expression patterns reflect distinct B cell differentiation stages in human germinal centers. J Immunol, 164, 1–4.
Raaphorst FM, Otte AP, van Kemekade FJ, Blokzijl T, Fieret E, Hamer KM, Satijn DPE and Meijer CLJM (2001) Distinct BMI‐1 and EZH2 expression patterns in thymocytes and mature T cells suggest a role for Polycomb genes in human T cell differentiation. J Immunol, 166, 5925–5934.
Ren B, Cam H, Takahashi Y, Volkert T, Terragni J, Young RA and Dynlacht BD (2002) E2F integrates cell cycle progression with DNA repair, replication and G2/M checkpoints. Genes Dev, 16, 245–256.
Rugarli EI, Lutz B, Kuratani SC, Wawersik S, Borsani G, Ballabio A and Eichele G (1993) Expression pattern of the Kallmann syndrome gene in the olfactory system suggests a role in neuronal targeting. Nat Genet, 4, 19–26.
Sage J, Mulligan GJ, Attardi LD, Miller A, Chen S, Williams B, Theodorou E and Jacks T (2000) Targeted disruption of the three Rb‐related genes leads to loss of G(1) control and immortalization. Genes Dev, 14, 3037–3050.
Sherr CJ and DePinho RA (2000) Mitotic clock or culture shock? Cell, 102, 407–410.
Suzuki A and Hemmati‐Brivanlou A (2000) Xenopus embryonic E2F is required for the formation of ventral and posterior cell fates during early embryogenesis. Mol Cell, 5, 217–229.
Trimarchi JM and Lees JA (2002) Sibling rivalry in the E2F family. Nat Rev Mol Cell Biol, 3, 11–20.
Varambally S et al. (2002) The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature, 419, 624–629.
Visser HPJ, Gunster MJ, Kluin‐Nelemans HC, Manders EMM, Raaphorst RM, Meijer CJLM, Willemze R and Otte AP (2001) The Polycomb group protein EZH2 is upregulated in proliferating, culture mante cell lymphoma. Br J Haematol, 112, 950–958.
Wallrapp C, Muller‐Pillasch F, Solinas‐Toldo S, Lichter P, Friess H, Buchler M, Fink T and Gress TM (1997) Characterization of a high copy number amplification at 6q24 in pancreatic cancer identifies c‐myb as a candidate oncogene. Cancer Res, 57, 3135–3139.
Weinmann AS, Bartley SM, Zhang T, Zhang MQ and Farnham PJ (2001) Use of chromatin immunoprecipitation to clone novel E2F target promoters. Mol Cell Biol, 21, 6820–6832.
Weinmann AS, Yan PS, Oberley MJ, Huang TH‐M and Farnham PJ (2002) Isolating human transcription factor targets by coupling chromatin immunoprecipitation and CpG island microarray analysis. Genes Dev, 16, 235–244.
Acknowledgements
We thank Daniele Piccini for the generation of anti‐EED antibody, Emma Hickman for help in performing MEF assays, Emmanuela Frittoli for help with microinjection experiments, Manuela Nebuloni and Renzo Boldorini for providing tumor material, Micaela Quarto and Marco Bianchi for generation of TMAs and for ISH analysis, Eros Lazzerini‐Denchi for his expertise in mouse myoblast differentiation and critical reading of the manuscript and Patrizia Gasparini for technical advice regarding FISH analysis. We thank Bruno Amati, Jiri Bartek, Thomas Jenuwein, Arie Otte and Liang Zhu for providing valuable reagents. We thank Maarten van Lohuizen, Pier Giuseppe Pelicci, Chris Marine and members of the Helin laboratory for discussions. We thank Luciano di Croce and Claire Attwooll for critical reading of the manuscript. This work was supported by grants from AIRC, FIRC, The European Union Fifth Framework Program, The Italian Health Ministry and the Human Science Frontiers Science Program.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary data
Supplementary data are available at The EMBO Journal Online.
Supplementary information
Rights and permissions
About this article
Cite this article
Bracken, A.P., Pasini, D., Capra, M. et al. EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer. EMBO J 22, 5323–5335 (2003). https://doi.org/10.1093/emboj/cdg542
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1093/emboj/cdg542
Keywords
This article is cited by
-
Retinoids and EZH2 inhibitors cooperate to orchestrate anti-oncogenic effects on bladder cancer cells
Cancer Gene Therapy (2024)
-
Exploiting the fibroblast growth factor receptor-1 vulnerability to therapeutically restrict the MYC-EZH2-CDKN1C axis-driven proliferation in Mantle cell lymphoma
Leukemia (2023)
-
UHRF1/UBE2L6/UBR4-mediated ubiquitination regulates EZH2 abundance and thereby melanocytic differentiation phenotypes in melanoma
Oncogene (2023)
-
EZH2 Contributes to Anoikis Resistance and Promotes Epithelial Ovarian Cancer Peritoneal Metastasis by Regulating m6A
Current Medical Science (2023)
-
Diverse and dynamic forms of gene regulation by the S. cerevisiae histone methyltransferase Set1
Current Genetics (2023)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.